NUTRA PHARMA (NPHC) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 22 118 sessions, October 27, 2025 to October 27, 2026
- Largest daily move
- +200% close of January 2, 2026
- 1-year change
- +0% closing prices, October 27, 2025 to October 27, 2026
- 1-month change
- +0% closing prices, September 23, 2026 to October 27, 2026
Company Description
NUTRA PHARMA (OTC: NPHC) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $716.0K.
NPHC has gained 0.0% over the past year. The last closing price was $0.0001.
For FY2025, NUTRA PHARMA reported revenue of $258K with net income of -$2.0M and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for NPHC, including price data, latest news, SEC filings, and financial highlights.
Stock Performance
NUTRA PHARMA (NPHC) closed at $0.0001 on October 27, 2026. Over the past 12 months, the price has gained 0.0%.
NPHC Metrics & Rankings
Price returns through October 27, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NUTRA PHARMA has 7 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. View all NPHC news →
SEC Filings
NUTRA PHARMA has filed 10 recent SEC filings, including 4 Form 10-Q, 1 Form 3, 1 Form 4, 1 Form 8-K. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NPHC SEC filings →
Financial Highlights
NUTRA PHARMA generated $258K in revenue in FY2025, retaining a 76.3% gross margin, operating income reached -$1.5M, and net income was -$2.0M. Diluted earnings per share stood at $0.00. The company generated -$1.2M in operating cash flow. The current ratio was 0.03, measuring current assets divided by current liabilities.
Upcoming Events
NPHC Company Profile & Sector Positioning
NUTRA PHARMA (NPHC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing NPHC often look at related companies in the same sector, including KAYA HOLDINGS INC (KAYS), PHARMADRUG INC (LMLLF), MAPLE LEAF GREEN WRLD INC (MGWFF), ADASTRA HOLDINGS LTD (XTXXF), and CANN AMERICAN CORP (CNNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NPHC's relative position within its industry.